N@N

Steven Lichtman Maintained (ZBH) at Buy with Increased Target to $142 on, Feb 6th, 2023

Steven Lichtman of Oppenheimer, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Increased Target from $120 to $142 on, Feb 6th, 2023.

Steven has made no other calls on ZBH in the last 4 months.

There are 10 other peers that have a rating on ZBH. Out of the 10 peers that are also analyzing ZBH, 5 agree with Steven's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Robbie Marcus of "JP Morgan" Maintained at Hold with Decreased Target to $18 on, Wednesday, January 11th, 2023
• Matthew O'Brien of "Piper Sandler" Maintained at Hold with Increased Target to $130 on, Thursday, January 5th, 2023
• Vijay Kumar of "Evercore ISI Group" Downgraded from Buy to Hold and Held Target at $130 on, Tuesday, January 3rd, 2023
• Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $130 on, Monday, December 12th, 2022
• Larry Biegelsen of "Wells Fargo" Upgraded from Sell to Hold and Increased Target to $124 on, Wednesday, November 23rd, 2022

These are the ratings of the 5 analyists that currently disagree with Steven

---

• Rick Wise of "Stifel" Maintained at Strong Buy and Held Target at $150 on, Sunday, February 5th, 2023
• Shagun Singh of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $141 on, Monday, January 9th, 2023
• Jayson Bedford of "Raymond James" Upgraded from Hold to Buy and Held Target at $144 on, Thursday, January 5th, 2023
• Matt Miksic of "Barclays" Initiated at Sell and Held Target at $104 on, Tuesday, October 18th, 2022
• Matthew Taylor of "Jefferies" Initiated at Sell and Held Target at $95 on, Wednesday, October 12th, 2022

Contributing Sources

---